Some types of PD-1 and PD-L1 inhibitors are available as subcutaneous injections that a cancer care ... The Food and Drug Administration (FDA) has approved Tecentriq Hybreza to treat certain ...

Teva Pharmaceuticals and Alvotech have announced that the US Food and Drug Administration (FDA) has approved the Selarsdi ...

The subcutaneous formulation of daratumumab makes treatment a faster and more tolerable process for patients with multiple ...

Zepbound (tirzepatide) is a prescription drug that’s used for weight loss and obstructive sleep apnea in certain adults. Zepbound comes as a liquid solution inside prefilled injection pens.

It is the second drug in the PD-1/PD-L1 inhibitor class to be cleared in a subcutaneous injection form by the FDA after Roche's Tecentriq Hybreza (atezolizumab and hyaluronidase) – which got a ...

Your doctor will help you decide which type is best for you, depending on your insulin dose, comfort level, and cost factors. Whether you’re new to giving yourself insulin injections or it’s a ...

From the collar to the kibble, you’ve purchased all of the necessary accoutrements associated with bringing a new pet into your home. Or have you? In those initial starry-eyed moments, chances are you ...